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ABSTRACT 
Background: Previous studies have shown that feeding high-energy formula to infants 
after cardiac surgery increased energy intake with fewer side effects on 
cardiopulmonary function. However, impacts on weight gain and gastrointestinal 
function remain unclear. 
Aims: To determine the impact of high-energy formula compared to standard formula 
on weight gain and gastrointestinal tolerance in postoperative infants with congenital 
heart disease. 
Design: Randomised Controlled Trial. 
Method: The setting of the study was at a 20-bed Cardiac Intensive Care Unit at a 
tertiary children’s hospital in China. Study population were infants <1 year of age who 
underwent cardiac surgery were allocated to the intervention group (n=32) and control 
group (n=32). The intervention group received high-energy formula (100kcal/100 mL) 
and the control group received standard formula (67kcal/100 mL) for 7 days during the 
stabilized postoperative period at the Cardiac Intensive Care Unit. Primary outcomes 
were weight gain and gastrointestinal intolerance. Secondary outcomes were energy 
intake and standard intensive care characteristics. 
Results: Infants who received high-energy formula (n=30) showed greater mean 
weight gain than those who received standard formula (n=29); -16g (95% CI: -74 to 42) 
versus -181g (95%CI: -264 to -99), P =0.001. The evaluation of gastrointestinal 
intolerance showed that the intervention group had several side effects, such as 
abdominal distension (n=1), gastric retention (n=2), and diarrhea (n=1), while the 
control group had no problems. Enteral energy intake in the intervention group was 
higher than control group from day three. 
Conclusion: Infants after cardiac surgery fed with high-energy formula gained more 
weight but had increased feeding intolerance. However, the feeding intolerance 
symptoms could be relieved by medication and did not affect feeding advancement. 
Relevance to Clinical Practice: Paediatric intensive care clinicians should consider 
gradually increasing energy density of the formula during feeding and assess feeding 
intolerance signs in children with malnutrition after cardiac surgery.  
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INTRODUCTION 
Congenital Heart Disease (CHD) is one of the most common prenatal defects 
comprising structural abnormalities of the heart and great vessels with a reported 
incidence of 6~10 per 1,000 live births (Van der Linde D et al., 2011). Infants with CHD 
are usually born at full term and have a normal birth weight. However, their growth 
might gradually become underdeveloped over time. Approximately 20-50% of children 
with CHD suffer from malnutrition (Costello et al., 2015; Toole et al., 2014; Monteiro 
et al., 2012), which is highest in infants (Dalili et al., 2011; Ratanachu-Ek et al., 2011). 
With new advances in surgery and perioperative technologies, surgical treatment 
of CHD is becoming more common in infants, including neonates. Early surgical 
intervention can reduce the occurrence of heart failure and helps to promote growth 
such that weight and growth rates become more normal (Daymont et al., 2013). 
However, the intense stress response, reperfusion injury, hyper-metabolism, and 
mechanical ventilation in infants with CHD can lead to increased energy needs (Irving 
et al., 2013; De Wit et al., 2010; Trabulsi et al., 2015). Although current studies agree 
that the energy needs are highly variable between patients in the immediate post-
operative period, there are several factors which can aggravate malnutrition in children 
and seriously affect their mortality, such as inadequate food intake, malabsorption 
(Hong et al., 2014), fluid restriction (Leong et al., 2014; Tume et al., 2013), various 
medications (Laura et al., 2012; Dong et al., 2012), and postoperative complications 
(Zuluaga, 2012; Iannucci et al., 2013). Nurses are concerned about the nutrition of 
children while evidence suggest that high-energy feed might be important for some 
postoperative infants with CHD (Wong et al., 2015). High-energy feeds can counteract 
the problem with fluid restriction and inadequate food intake.  
Energy density refers to food that contain a high number of calories per serving or 
weight. These foods include those that are concentrated and those with a high fat 
content. Food concentrates reduce water intake without reducing the nutrient supply, 
whereas additional supplements that increase nutrient intake can increase energy 
density. Several clinical studies (Pillo-Blocka et al., 2004; Taniguchi-Fukatsu et al., 
2010) were designed to explore the effects of feeding high-energy formula (HF) to 
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infants with CHD. The results from these studies showed that feeding HF increased 
calorie intake with fewer side effects on cardiopulmonary function. Yet, we do not have 
strong evidence on calorie intake (Tume et al., 2010) and the impact on weight gain and 
gastrointestinal function remains unclear. 
The aim of this study was to assess the efficacy and safety of feeding HF to early 
postoperative infants with CHD. Our hypothesis was that infants with CHD fed with 
HF gain more weight with no gastrointestinal intolerance compared with those fed with 
standard-energy formula (SF).  
 
DESIGN AND METHODS 
Study design and setting 
A randomised controlled clinical trial was conducted from March 18, 2015, to 
September 28, 2015 in the Cardiac Intensive Care Unit (CICU) of our hospital. 
Participants 
Inclusion criteria were: diagnosed with CHD based on symptoms, ultrasound, and 
imaging; <1 year of age; and parent agreement to open-heart surgery. The exclusion 
criteria were: other diseases that caused nutritional disorders (gastrointestinal 
malformation, preoperative gastroesophageal reflux, or genetic diseases related to 
growth restriction); preoperative gastrointestinal intolerance (e.g., gastric retention, 
abdominal distension, diarrhea, and vomiting); total parenteral nutrition after surgery; 
or length-of-stay in the Cardiac Intensive Care Unit (CICU) was predicted to be <5 
days. 
A randomized block design was created to ensure a balanced representation of the 
study participants in the two groups. There were four variables in each block, and the 
sequence was determined using computer-generated random numbers. The final 
sequences were respectively sealed in 64 encoded opaque envelopes. The statistician 
generated the random allocation sequence and envelopes. The CICU chief doctor and 
researcher enrolled participants by the envelope sequence. 
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Sample size 
The patients were divided into two groups: an intervention group and a control group. 
Based on Jackson’s study (Jackson et al., 1991), citing an average rate of weight gain 
of 1.3 g/d (SD=0.7) in the control group and 5.8 g/d in the intervention group (SD=1.2), 
and considering α error rate of 5%, 80% power, partition ratio=1, superior efficiency 
value = 4.0 g, and 20% loss rate, 32 children needed to be recruited for each group in 
the study (Jia et al., 2012). 
Intervention 
1. Intervention methods 
Infants in the intervention group were fed with HF (100 kcal/100 mL; osmotic pressure: 
340 mOsm/L; a standard milk powder with 2.6g protein, 5.4g fat, 9.9g carbohydrate 
and other vitamins and trace elements per 100ml) after surgery once they could begin 
enteral feeding. Infants in the control group were fed with SF (67 kcal/100 mL; osmotic 
pressure: 310 mOsm/L; a standard milk powder with 2.0g protein, 3.4g fat, 7.0g 
carbohydrate and other vitamins and trace elements per 100ml). The intervention 
continued for 7 days. The CICU chief doctor and researcher enrolled participants by 
the envelope sequence. During the study period, when the patient could start enteral 
nutrition, the chief doctor would prescribe a diet (type of milk, amount and frequency) 
in the medical order system. Then, the nutrition department prepared the milk according 
to medical prescription and pasted patients’ hospitalization information (name and 
admission number) on the bottle. The nurses fed the infants according to medical advice. 
The bottles were not coded or blinded because non-study participants admitted to the 
CICU at time of the study were also receiving milk. Blinding of the CICU doctors and 
nurses was secured by not informing them which child was included in the study.  
2. Enteral feeding methods 
Both groups were fed according to our standard enteral feeding protocol that is used 
among all infants in the CICU (Electronic Supplement Material 1). Six hours after 
surgery, a comprehensive assessment every 12 hour was performed by doctors and 
nurses to determine whether infants could begin enteral feeding. Enteral feeding was 
initiated after the following items were adequate: hemodynamic status; heart rate, blood 
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pressure, central venous pressure, and SpO2 were at desired levels; Gastric Residual 
Volumes (GRV) was decreased and the colour was normal; and there were no 
symptoms of abdominal distension and gastrointestinal infection. 
Infants with mechanical ventilation were fed through a nasogastric tube. To choose 
the appropriate feeding method, doctors and nurses were responsible for assessing the 
infant’s feeding capability based on the suck–swallow coordination, sucking ability, 
feeding completion time, and changes in life signs during feeding. Infants with poor 
oral intake capability were fed through a nasogastric tube only or nasogastric tube 
combined with oral feeding.  
The initial volume of enteral feeding was 10 mL/kg/d with a target volume of 
100~120 mL/kg/d. If the infant’s gastrointestinal system tolerated the initial volume, 
feeding was gradually increased to the standard rate of 20~30 mL/kg/d. When the diet 
given was only mildly intolerant, gastrointestinal motility and microecological drugs 
(e.g., domperidone, medilac-vita, glycerin enema, and smecta) were preferred to 
decrease enteral feeding volume or stop feeding altogether. In addition, if 
gastrointestinal bleeding occurred, enteric feeding was stopped until the bleeding was 
under control. 
Outcome measures 
The primary outcome measures were: weight gain (g) by the seventh day from the 
beginning of the enteral feeding; and feeding intolerance from the first day to the 
seventh day after starting enteral feeding. Infants were considered to have feeding 
intolerance if any of the following symptoms appeared vomiting no less than three 
times/day, abdominal distension (abdominal circumference increased by more than 
10%), milk volume decrease or no increase for 3 days, GRV > 1/3 of the previous feed, 
unscheduled feeding stops more than twice, or diarrhoea. 
The secondary outcomes were measured as follows: prealbumin (mg/L) was 
assessed within 24 hours after surgery (baseline) and at 3 and 7 days during intervention 
period; enteral energy intake every day during intervention period; duration of 
mechanical ventilation, CICU length-of-stay, hospital length-of-stay, and number of 
participants with necrotizing enterocolitis. 
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Data Analysis 
All data were initially tested for normality of distribution. An independent Student's t-
test was used when appropriate. Data that were non-transformable to normal 
distributions were compared using the Mann-Whitney U test for ranked scores. Fisher’s 
exact test was used to assess frequency distribution. The results are presented by mean 
and SD (for normally distributed variables) or median and quartile for non-normally-
distributed variables or frequency/percentage for categorical variables. P <0.05 was 
considered statistically significant. Analyses were performed using SPSS 22 (IBM 
Corp., Armonk, NY, USA). 
Ethical and research approvals 
The randomised controlled trial was approved by the Pediatric Research Ethics Board 
of the Clinical Pharmacology Base in our hospital, on October 18, 2014 (Approval 
number: [2014]146), and registered at the National Institutes of Health 
(ClinicalTrials.gov; NCT02389491). Parents or legal guardians of all study participants 
provided a signed informed consent form. 
 
RESULTS 
In total, 64 infants were recruited, and 59 infants completed the trial (intervention group 
n=30; control group n=29). Five infants dropped out because of death, formula change 
and relocation to another hospital (Electronic Supplement Material 2). The median age 
of infants was 60 days (range: 35-120 days), and the mean preoperative body weight 
was 4880g (SD=1431.8). The two groups did not significantly differ in any of the 
baseline characteristics before intervention (Table 1). 
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Table 1. Patient Demographics 
 
Characteristics 
Intervention group 
(n = 30) 
Control  
group 
(n = 29) 
P-
value 
Gender; Male, (n; %) 19 (63.3) 20 (69.0) 0.648 
Premature; Yes, (n; %) 2 (6.9) 2 (7.1) 1.000 
Age in days; Median, (P25-P75) 60.0 (35.2 - 127.5) 63.0 (34.5 - 120.0) 0.964 
Birth weight in grams; Median, (P25–P75) 
3300.0  
(3100.0 - 3600.0) 
3425.0  
(3125.0 - 3600.0) 
0.719 
Preoperative body weight in grams; mean, 
(SD) 
4629.9 (1086.4) 5138.0 (1699.5) 0.179 
Preoperative serum prealbumin, mg/L; mean, 
(SD) 
174.30 (58.21) 167.00 (50.42) 0.609 
Diagnosis; (n; %)    
VSD +ASD 11 (36.7) 10 (34.5) 
0.173 
TGA 4 (13.3) 7 (24.1) 
TOF 2 (6.7) 5 (17.2) 
TAPVC 6 (20.0) 1 (3.4) 
DORV 1 (3.3) 3 (10.3) 
Other 6 (20.0) 3 (10.3) 
Delayed sternal closure; Yes, (n; %) 4 (13.3) 7 (24.1) 0.287 
CPB blocking time, minutes; mean, (SD) 95.37 (47.11) 97.41 (31.82) 0.846 
Aortic clamping time, minutes; mean, (SD) 53.37 (26.45) 54.18 (23.65) 0.903 
Minimum rectal temperature, ℃; mean, (SD) 30.85 (3.19) 31.01 (3.47) 0.857 
Time to start enteral feeding, hours; mean, 
(P25-P75) 
52.67 (48.00-71.77) 71.00 (48.42- 91.92) 0.234 
Continuous use of diuretics; Yes, (n; %) 3 (10.0) 7 (24.1) 0.148 
Use of blood products; Yes, (n; %) 4 (13.3) 2 (6.9) 0.413 
SD, Standard Deviation; VSD, ventricular septal defects; ASD, atrial septal defect; 
TGA, transposition of the great arteries; TOF, tetralogy of fallot; TAPVC, total 
anomalous pulmonary venous connection; DORV, double outlet right ventricle 
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Infants who received HF showed greater mean weight gain than those who received 
SF: -16g (95% CI: -74 to 42) versus -181g (95%CI: -264 to -99), P=0.001. Mean weight 
gain is negative. This means the average body weight of both group infants were lower 
than before. The evaluation of gastrointestinal intolerance revealed that the intervention 
group had several problems (abdominal distension (n=1), GRV > 1/3 of the previous 
feed (n=2), and diarrhoea (n=1)), while infants in the control group showed no 
gastrointestinal problems. There were 9 infants using drugs for improving 
gastrointestinal function in the intervention group (domperidon (n=5), medilac-vita 
(n=5), and enema (n=2)), while 6 infants in the control group (domperidon (n=2), 
medilac-vita (n=4), enema (n=2), and smecta (n=1)). 
The serum prealbumin levels gradually increased in the intervention group and 
declined in the control group (Day 3: 188mg/L versus 175 mg/L, P=0.128; Day 7: 
196mg/L versus 175 mg/L, P=0.002). The enteral nutrition energy intake of both groups 
gradually increased, with that of the intervention group increasing faster than the 
control group from day 3 (Figure 1). There was no statistical difference in the duration 
of mechanical ventilation (86hrs versus 89hrs, P=0.749), CICU length-of-stay (238hrs 
versus 191hrs, P=0.430), and hospital length-of-stay (29days versus 30days, P=0.769). 
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DISCUSSION 
The purpose of this study was to assess the efficacy and safety of feeding high-energy 
formula to early postoperative infants with CHD. Our hypothesis was that infants with 
CHD fed with HF could gain more weight with no gastrointestinal intolerance 
compared with those fed a standard-energy formula. The gastrointestinal function of 
the study participants was negatively affected by several factors, including 
gastrointestinal tract ischemia and reperfusion injury after cardiopulmonary bypass, 
postoperative mechanical ventilation, and vasoactive drugs. However, clinical staff 
were sensible in providing early enteral nutrition and infants were given formula milk 
(approximately 15-30 mL/kg/d) in the first 1-2 days after surgery. Fluid restriction was 
gradually decreased with improvement of heart function. Although there was no 
difference between the two groups in the amount of nutritional intake, HF given to the 
intervention group provided the infants with more energy intake and increased weight 
gain. 
Providing early nutrition to postoperative infants can improve clinical outcomes. 
Feeding protocols and adherence of clinical staff to these protocols can promote these 
practices (Mehta et al., 2017). The strength of our study was having an enteral feeding 
protocol in place which seems to be unique compared to a recent survey among 59 
European Pediatric Intensive Care Units (Tume et al., 2018). Only 39% of these units 
reported to have specific written guidelines in place for feeding postoperatively and 
only 30% of these units stated that all infants are routinely fed within 12–24 hours after 
surgery (Tume et al., 2018). 
 The body weight of study participants decreased, most likely from mechanical 
ventilation, early postoperative fluid restriction, or the use of diuretics. It is noteworthy 
that body weight began to rebound after 4-5 days of intervention mainly from adequate 
caloric intake. Other reports suggested that the resting energy expenditure of children 
with CHD was approximately 40-60 kcal/kg/d in the first 3-5 days after surgery (Mehta 
et al., 2012; Li et al., 2008). In our study, the intervention group was given 51-89 
kcal/kg/d during the intervention period compared with 44-56 kcal/kg/d given to the 
control group. The intervention group was overfeeding in certain degree, but there was 
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no difference in length of ventilation between the two groups, which may indicates that 
such feeding does not harm children. The residual energy intake of infants was in the 
form of synthetic metabolism; a small quantity was transformed into liver and muscle 
glycogen, which regulates the body’s blood sugar changes and supplies the needs for 
muscle contraction. The other intake was converted into fat or muscle for energy storage, 
which resulted in a weight increase in those participants who were fed the HF diet. This 
relationship between energy intake and weight gain was also observed in other studies, 
but there is still controversy over the dose–response relationship. One study suggested 
that the children continue to gain weight when the energy intake is >170 kcal/kg/d 
(Sables-Baus et al., 2012), while another study showed that at 78 kcal/kg/d there was 
no weight gain and that infants can achieve 1.0 g/d weight gain with each additional 
intake of 7.4 kcal/kg/d (Jackson et al., 1991). The level of serum albumin, which can 
rapidly increase in response to protein consumption and fluctuations in nutritional 
status, has a short half-life of 1-2 days and is less affected by liver disease. In our study, 
the serum albumin levels increased in the intervention group but decreased in the 
control group, which may indicates that HF feeding improved the nutritional status of 
the infants. 
The HF had a higher osmotic pressure (340 mOsm/L), which increased the risk of 
imbalance in the intestinal humoral system in these infants; consequently, three infants 
suffered from abdominal distension, diarrhoea, and gastric retention in the intervention 
group within nearly 1-3 days after the onset of HF feeding. Fortunately, this type of 
gastrointestinal intolerance was relieved with medication and did not affect the feeding 
process. By gradually increasing the formula density within the first 3 days of treatment, 
we believe that an infant’s gastrointestinal intolerance to HF can be improved. 
Limitations 
One of the limitations of our study is the blinding and assessments. Although the doctors 
and nurses were blinded in this study by not knowing which infant was included in the 
study, the outcome indicators such as abdominal distension might have been subjective 
and could be prone to reporting bias. Another limitation is the intervention time, which 
was limited to 7 days, and the follow-up data collection was limited to the CICU 
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admission time. In a follow-up study we will consider a prolonged intervention time to 
explore patient’s long-term clinical outcomes, such as weight gain during 
hospitalization, the incidence rate of postoperative complications, and length of hospital 
stay. Future studies should also consider expanding the sample size and other variables. 
Our sample size calculation included a 20% loss rate, resulting in 32 children in each 
group. Our final sample size was 30 in the intervention group and 29 in the control 
group. If we excluded the 20% loss rate, the total sample size in each group would be 
26 children justifying the results of primary outcome measure, weight gain. Although 
all children were fluid restricted and diuresed, weight gain in cardiac children might 
not be reliable in the acute phase as it may indicate generalised edema. Finally, the 
majority of the children assess for study eligibility had a predicted length-of-stay of less 
than 5 days reducing significantly the study sample.   
 
CONCLUSION 
High-energy formula enteral feeding might increase infant’s energy intake, reduce 
weight loss, and improve the nutritional status after CHD surgery. However, it can 
increase gastrointestinal intolerance within nearly 1-3 days after the onset of HF feeding. 
In addition, this kind of gastrointestinal intolerance could be relieved by medication 
and did not affect the support of the feeding process. We were able to reduce the 
incidence of feeding intolerance by increasing the formula density gradually within 3 
days post cardiac surgery. More studies are needed to confirm the efficacy and safety 
of HF in infants with CHD. The clinical implication of our study is that clinicians should 
consider to gradually increase the energy density of the formula during feeding and 
assess feeding intolerance signs and symptoms in children after cardiac surgery. 
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WHAT IS KNOWN ABOUT THE SUBJECT 
⚫ High-energy formula feeding in infants with congenital heart disease after surgery 
can increased energy intake with limited side-effects on cardiopulmonary function. 
⚫ Limited evidence is available on the impact of high-energy formula feeding on 
weight gain and feeding intolerance.  
 
WHAT THIS PAPER CONTRIBUTES 
⚫ High-energy formula feeding might increase weight gain in infants after cardiac 
surgery. 
⚫ Feeding practice with high-energy formula in critically ill infants might lead to 
more gastrointestinal intolerance within 1-3 days after feeding. 
⚫ Intensive care nurses should be cautious when providing high-energy formula to 
infants and assess the gastrointestinal function frequently. 
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